The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1/2a, open-label, multicenter study of intramuscular (IM) abiraterone decanoate (PRL-02) depot in patients with advanced prostate cancer (NCT04729114).
 
Tim Warneke
Employment - Propella Therapeutics
Stock and Other Ownership Interests - BioDelivery Sciences International; Propella Therapeutics; Syneos Health (I)
 
Michael R. Kurman
Consulting or Advisory Role - Propella Therapeutics
Travel, Accommodations, Expenses - Propella Therapeutics
 
Robert Dreicer
Consulting or Advisory Role - Astellas Pharma; Bayer; Eisai; EMD Serono; Infinity Pharmaceuticals; Merck; Myovant Sciences; Pfizer; Pfizer/Astellas; Propella Therapeutics; Tavanta Therapeutics; Veru
Research Funding - Bristol-Myers Squibb (Inst); Exelixis (Inst); Novartis (Inst); Seagen (Inst)
 
Daniel J. George
Leadership - Capio BioSciences
Honoraria - Acceleron Pharma; American Association for Cancer Research; Axess Oncology; Bayer; EMD Serono; Exelixis; Janssen Oncology; Millennium Medical Publishing; OncLive; Pfizer; Sanofi; UroToday
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Constellation Pharmaceuticals; Exelixis; Genentech; Innocrin Pharma; Janssen; Merck Sharp & Dohme; Michael J. Hennessy Associates; Myovant Sciences; Pfizer; Physicans' Education Resource; Propella Therapeutics; Sanofi; Vizuri
Speakers' Bureau - Bayer; Exelixis; Sanofi
Research Funding - Acerta Pharma (Inst); Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Dendreon (Inst); Exelixis (Inst); Innocrin Pharma (Inst); Janssen Oncology (Inst); Novartis (Inst); Pfizer (Inst); Sanofi/Aventis (Inst)
Travel, Accommodations, Expenses - Bayer; Exelixis; Janssen Oncology; Merck; Pfizer; Sanofi; UroToday
 
Neal Shore
Honoraria - Abbvie; Amgen; Astellas Amgen BioPharama; AstraZeneca; Bayer Health; BMS Brazil; Boston Scientific; Clovis Oncology; Dendreon; Exact Imaging; FerGene; Foundation Medicine; GC Oncology; Genzyme; Invitae; Janssen; MDxHealth; Merck; Myovant Sciences; Myriad Pharmaceuticals; Nymox; Pfizer; Sanofi; Sesen Bio; Tolmar
Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; AstraZeneca; Bayer (I); BMS Brazil; Boston Scientific; Clovis Oncology; Dendreon; Exact Imaging; FerGene; Foundation Medicine; GC Oncology; Genzyme; Invitae; Janssen; MDxHealth; Merck; Myovant Sciences; Myriad Genetics; Nymox; Pfizer; Propella Therapeutics; Sanofi; Sesen Bio; Tolmar
Speakers' Bureau - Astellas Oncology; AstraZeneca; Bayer; Clovis Oncology; Guardant Health; Janssen; Pfizer
Research Funding - Abbvie; Amgen; Astellas Oncology; AstraZeneca; Bayer; BMS Brazil; Boston Scientific; Clovis Oncology; Dendreon; Exact Imaging; FerGene; Foundation Medicine; GC Oncology; Genzyme; Invitae; Janssen; MDxHealth; Merck; Myovant Sciences; Myriad Genetics; Nymox; Pfizer; Sanofi; Sesen Bio; Tolmar
 
William Douglas Figg
Research Funding - Astellas Pharma (Inst); Biocompatibles (Inst); Celgene (Inst); Nerviano Medical Sciences (Inst); NovaRX (Inst); Pfizer (Inst); TRACON Pharma (Inst)
 
Robert Schotzinger
Employment - Viamet Pharmaceuticals
Leadership - Propella Therapeutics; Viamet Pharmaceuticals
Stock and Other Ownership Interests - Propella Therapeutics; Viamet Pharmaceuticals
Consulting or Advisory Role - Propella Therapeutics
Patents, Royalties, Other Intellectual Property - Hold patents at Viamet Pharmaceuticals
 
William R. Moore
Employment - Propella Therapeutics; Vizuri
Leadership - Propella Therapeutics; Vizuri
Stock and Other Ownership Interests - Propella Therapeutics; Vizuri
Research Funding - Propella Therapeutics; Vizuri
Patents, Royalties, Other Intellectual Property - I'm an inventor on patents that were assigned to Propella Therapeutics that protect composition of matter, methods of use, and manufacturing of abiraterone decanoate
Travel, Accommodations, Expenses - Propella Therapeutics; Vizuri